HIF1A and non-small cell lung carcinoma: The 1-, 3- and 5-year postoperative survival rate of patients with NSCLC were 91%, 69%, 59% respectively, and not correlated with the plasma level of HIF-1α, age, gender, tumor differentiation grade, diameter of tumor and smoking status (P > 0.05).